Matthias Prager1, Janine Büttner, Carsten Büning. 1. Department of Hepatology and Gastroenterology, Universitätsmedizin Berlin, Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Germany.
Abstract
PURPOSE: Variants modulating expression of the prostaglandin receptor 4 (PTGER4) have been reported to be associated with Cohn's disease (CD), but the clinical impact remains to be elucidated. We analyzed these variants in a large German inflammatory bowel disease (IBD) cohort and searched for a potential phenotype association. METHODS: The variants rs4495224 and rs7720838 were studied in adult German IBD patients (CD, n = 475; ulcerative colitis (UC), n = 293) and healthy controls (HC, n = 467). Data were correlated to results from NOD2 genotyping and to clinical characteristics. RESULTS: We found a significant association for the rs7720838 variant with overrepresentation of the T allele to CD (p = 0.0058; OR 0.7703, 95 % CI 0.641-0.926) but not to UC. Furthermore, logistic regression analysis revealed that the presence of the T allele was associated with stricturing disease behavior in CD patients (p = 0.03; OR 1.84, 95 % CI 1.07-3.16). Interestingly, the chance for developing stricturing disease behavior was enhanced if mutant alleles in both rs7720838 and NOD2 were present (OR 2.87, 95 % CI 1.42-5.81; p = 0.003). No overall association to CD or UC was found for the rs4495224 variant. CONCLUSIONS: The PTGER4 modulating variant rs7720838 increases susceptibility for CD and might resemble a risk factor for stricturing disease behavior.
PURPOSE: Variants modulating expression of the prostaglandin receptor 4 (PTGER4) have been reported to be associated with Cohn's disease (CD), but the clinical impact remains to be elucidated. We analyzed these variants in a large German inflammatory bowel disease (IBD) cohort and searched for a potential phenotype association. METHODS: The variants rs4495224 and rs7720838 were studied in adult German IBDpatients (CD, n = 475; ulcerative colitis (UC), n = 293) and healthy controls (HC, n = 467). Data were correlated to results from NOD2 genotyping and to clinical characteristics. RESULTS: We found a significant association for the rs7720838 variant with overrepresentation of the T allele to CD (p = 0.0058; OR 0.7703, 95 % CI 0.641-0.926) but not to UC. Furthermore, logistic regression analysis revealed that the presence of the T allele was associated with stricturing disease behavior in CDpatients (p = 0.03; OR 1.84, 95 % CI 1.07-3.16). Interestingly, the chance for developing stricturing disease behavior was enhanced if mutant alleles in both rs7720838 and NOD2 were present (OR 2.87, 95 % CI 1.42-5.81; p = 0.003). No overall association to CD or UC was found for the rs4495224 variant. CONCLUSIONS: The PTGER4 modulating variant rs7720838 increases susceptibility for CD and might resemble a risk factor for stricturing disease behavior.
Authors: Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren Journal: Can J Gastroenterol Date: 2005-09 Impact factor: 3.522
Authors: Rishabh Sehgal; Arthur Berg; Joseph I Polinski; John P Hegarty; Zhenwu Lin; Kevin J McKenna; David B Stewart; Lisa S Poritz; Walter A Koltun Journal: Dis Colon Rectum Date: 2012-03 Impact factor: 4.585
Authors: M Nitta; I Hirata; K Toshina; M Murano; K Maemura; N Hamamoto; S Sasaki; H Yamauchi; K Katsu Journal: Scand J Immunol Date: 2002-07 Impact factor: 3.487
Authors: C Büning; J Genschel; S Bühner; S Krüger; K Kling; A Dignass; P Baier; B Bochow; J Ockenga; H H-J Schmidt; H Lochs Journal: Aliment Pharmacol Ther Date: 2004-05-15 Impact factor: 8.171
Authors: Anna Latiano; Orazio Palmieri; Tiziana Latiano; Giuseppe Corritore; Fabrizio Bossa; Giuseppina Martino; Giuseppe Biscaglia; Daniela Scimeca; Maria Rosa Valvano; Maria Pastore; Antonio Marseglia; Renata D'Incà; Angelo Andriulli; Vito Annese Journal: PLoS One Date: 2011-07-27 Impact factor: 3.240
Authors: Jürgen Glas; Julia Seiderer; Darina Czamara; Giulia Pasciuto; Julia Diegelmann; Martin Wetzke; Torsten Olszak; Christiane Wolf; Bertram Müller-Myhsok; Tobias Balschun; Jean-Paul Achkar; M Ilyas Kamboh; Andre Franke; Richard H Duerr; Stephan Brand Journal: PLoS One Date: 2012-12-27 Impact factor: 3.240
Authors: Cécile Libioulle; Edouard Louis; Sarah Hansoul; Cynthia Sandor; Frédéric Farnir; Denis Franchimont; Séverine Vermeire; Olivier Dewit; Martine de Vos; Anna Dixon; Bruno Demarche; Ivo Gut; Simon Heath; Mario Foglio; Liming Liang; Debby Laukens; Myriam Mni; Diana Zelenika; André Van Gossum; Paul Rutgeerts; Jacques Belaiche; Mark Lathrop; Michel Georges Journal: PLoS Genet Date: 2007-03-05 Impact factor: 5.917
Authors: José A Cornejo-García; James R Perkins; Raquel Jurado-Escobar; Elena García-Martín; José A Agúndez; Enrique Viguera; Natalia Pérez-Sánchez; Natalia Blanca-López Journal: Front Pharmacol Date: 2016-09-21 Impact factor: 5.810
Authors: Damian Maseda; Amrita Banerjee; Elizabeth M Johnson; Mary Kay Washington; Hyeyon Kim; Ken S Lau; Leslie J Crofford Journal: Front Immunol Date: 2018-12-14 Impact factor: 7.561